A case of galactorrhea associated with excitalopram

Psychiatry Investigation

Volumn 6, Issue 3, 2009, Pages 230-232

  Shim, Se Hoon ^a   Lee, Yeon Jeong ^a   Lee, Eun Chan ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b DANA Hospital   (South Korea)

Author keywords

Depression; Escitalopram; Galactorrhea; Prolactin; Side effect

Indexed keywords

ESCITALOPRAM; PROLACTIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; MASTALGIA; NEUROTRANSMISSION; PROLACTIN BLOOD LEVEL;

EID: 70350046262     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.3.230     Document Type: Article

References (20)

1. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003;182:199-204. (Pubitemid 36286731)
2. Checkley S. Neuroendocrine effects of psychotropic drugs. Baillieres Clin Endocrinol Metab 1991;5:15-33.
3. Hall MJ. Breast tenderness and enlargement induced by sertraline. Am J Psychiatry 1994;151:1395-1396.
4. Peterson MC. Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc 2001;76:215-216.
5. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997;17:292-297. (Pubitemid 27312428)
6. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
8. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc 2005;44:456-465.
9. Beck AT. Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper & Row; 1967.
10. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D Scales. Korean J Clin Psychol 1991;10:98-113.
11. Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, et al. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 2004;65:1064-1068.
12. Seifritz E, Baumann P, Müller MJ, Annen O, Amey M, Hemmeter U, et al. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology 1996;14:253-263.
13. Nicholas L, Dawkins K, Golden RN. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am 1998;21:341-358.
14. Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994;165:728-733.
15. Meltzer HY, Young M, Metz J Fang VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979;45:165-175. (Pubitemid 9173410)
16. Kim SW, Dysken MW. Potential antidopaminergic effects of serotonin reuptake inhibitors. J Clin Psychiatry 1991;52:42.
17. Kiss J, Halász B. Synaptic connections between serotoninergic axon terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus of the rat hypothalamus. A combination of electron microscopic autoradiography and immunocytochemistry. Brain Res 1986;364:284-294.
18. Mirkes SJ, Bethea CL. Oestrogen, progesterone and serotonin converge on GABAergic neurones in the monkey hypothalamus. J Neuroendocrinol 2001;13:182-192.
19. Gulsun M, Evrensel A, Verim S. Galactorrhea during escitalopram treatment: a case report. Bull Clin Psychopharmacol 2006;16:39-41.
20. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med 2007;37:275-278.